
National Research Corporation NRC
€ 16.39
-0.1%
Quartalsbericht 2026-Q1
hinzugefügt 06.05.2026
National Research Corporation ROCE 2011-2026 | NRC
ROCE Jährlich National Research Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 161.47 | 112.5 | 81.8 | 64.61 | 58.91 | 66.36 | 59.33 | 57.9 | 36.02 | 35.01 | 31.14 | 27.85 | 28.41 | - | - | 28.52 | 31.01 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 161.47 | 27.85 | 58.72 |
ROCE Vierteljährlich National Research Corporation
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 131.74 | 113.52 | 81.52 | 97.78 | 68.81 | 86.01 | 75.01 | 65.03 | 41.32 | 57.72 | 57.27 | 59.58 | 47.5 | 63.3 | 62.94 | 62.6 | 48.24 | 66.93 | 65.55 | 66.93 | 50.52 | 81.59 | 93.75 | 111.87 | 94.47 | 142.5 | 152.07 | 168.16 | 135.62 | 143.53 | 104.88 | 75.33 | 28.38 | 37.25 | 37.81 | 38.09 | 27.01 | 35.83 | 35.54 | 34.92 | 25.25 | 33.41 | 31.79 | 32.79 | 24.93 | 33.33 | 32.89 | 35.75 | 26.17 | 36.12 | 36.91 | 39.92 | 29.86 | 37.41 | 34.36 | 35.42 | 24.71 | 7.55 | 6.9 | 10.26 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 168.16 | 6.9 | 60.4 |
ROCE anderer Aktien in der Diagnostik & Forschung
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | ||
|
Agilent Technologies
A
|
25.0 | $ 115.5 | 0.47 % | $ 35.1 B | ||
|
Celcuity
CELC
|
-171.24 | $ 133.31 | -3.56 % | $ 6.23 B | ||
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-236.6 | $ 9.61 | 89.55 % | $ 12.8 M | ||
|
Castle Biosciences
CSTL
|
-9.09 | $ 19.6 | -2.73 % | $ 568 M | ||
|
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
63.01 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | ||
|
Fulgent Genetics
FLGT
|
-8.19 | $ 17.77 | 3.89 % | $ 547 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
-10.16 | $ 21.37 | -1.2 % | $ 1.14 B | ||
|
Guardant Health
GH
|
440.3 | $ 119.71 | 0.63 % | $ 15 B | ||
|
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-69.04 | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | ||
|
Interpace Biosciences
IDXG
|
18.26 | $ 1.8 | -1.1 % | $ 7.96 M | ||
|
ICON Public Limited Company
ICLR
|
4.69 | $ 113.63 | -2.7 % | $ 9.37 B | ||
|
Illumina
ILMN
|
-35.1 | $ 144.69 | 0.19 % | $ 23 B | ||
|
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | ||
|
Lantheus Holdings
LNTH
|
28.52 | $ 101.47 | -1.49 % | $ 6.85 B | ||
|
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
0.8 | $ 155.9 | -2.74 % | $ 7.73 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | ||
|
Mettler-Toledo International
MTD
|
35.8 | $ 1 106.55 | 0.31 % | $ 22.8 B | ||
|
Medpace Holdings
MEDP
|
116.53 | $ 429.82 | -0.69 % | $ 12.4 B | ||
|
NeoGenomics
NEO
|
-9.11 | $ 9.33 | 1.08 % | $ 1.2 B | ||
|
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | ||
|
Natera
NTRA
|
-76.66 | $ 198.65 | -2.23 % | $ 19.5 B | ||
|
Myriad Genetics
MYGN
|
-105.22 | $ 3.86 | 0.92 % | $ 357 M | ||
|
Personalis
PSNL
|
-33.71 | $ 8.99 | 6.08 % | $ 802 M | ||
|
Koninklijke Philips N.V.
PHG
|
7.33 | $ 26.93 | -0.07 % | $ 25.5 B | ||
|
Senseonics Holdings
SENS
|
-111.94 | $ 6.44 | 1.58 % | $ 269 M | ||
|
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
2.09 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-125.14 | $ 2.47 | -0.8 % | $ 5.67 M | ||
|
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 259.94 | - | $ 21.6 B | ||
|
Twist Bioscience Corporation
TWST
|
-28.81 | $ 64.56 | 6.59 % | $ 3.86 B | ||
|
Thermo Fisher Scientific
TMO
|
14.5 | $ 448.93 | 0.14 % | $ 169 B | ||
|
Trinity Biotech plc
TRIB
|
-29.73 | $ 0.64 | 5.48 % | $ 230 M | ||
|
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
-51.22 | $ 9.19 | 3.2 % | $ 1.99 B | ||
|
Waters Corporation
WAT
|
7.05 | $ 339.53 | -0.83 % | $ 20.2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 193.27 | -0.99 % | $ 21.5 B |